1. Home
  2. Browse Decisions
  3. F.3d
  4. 940 F.3d
  5. 940 F.3d 680 (2019)
 

HZNP MEDICINES LLC v. ACTAVIS LABORATORIES UT

2017-2149, 2017-2152, 2017-2153, 2017-2202, 2017-2203, 2017-2206.

940 F.3d 680 (2019)

HZNP MEDICINES LLC, Horizon Pharma USA, Inc., Plaintiffs-Appellants v. ACTAVIS LABORATORIES UT, INC., Defendant-Cross-Appellant.

United States Court of Appeals, Federal Circuit.

Decided: October 10, 2019.

Attorney(s) appearing for the Case

Caryn Borg-Breen , Green, Griffith & Borg-Breen LLP, Chicago, IL, argued for all plaintiffs-appellants. Also represented by Robert Fritz Green , Jessica Mackay .

Michael E. Joffre , Sterne Kessler Goldstein & Fox, PLLC, Washington, DC, argued for defendant-cross-appellant. Also represented by John Christopher Rozendaal , Kristina Caggiano Kelly , William H. Milliken .

Opinion concurring in part and dissenting in part filed by Circuit Judge Newman.

HZNP Medicines LLC and Horizon Pharma USA, Inc. ("Horizon") appeal from the U.S. District Court for the District of New Jersey's judgment of invalidity and noninfringement. Actavis Laboratories UT, Inc. ("Actavis") cross-appeals the district court's judgment of nonobviousness. We affirm.

BACKGROUND

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases